Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Partial Neuromuscular Blockade by Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea-before and After Three Month CPAP Treatment. A Non-randomized, Non-blinded Study.

NCT01672606 is registered in ClinicalTrials.gov with Malin Jonsson Fagerlund as lead sponsor.

NCT NCT01672606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01672606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Partial Neuromuscular Blockade by Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea-before and After Three Month CPAP Treatment. A Non-randomized, Non-blinded Study.
Lead sponsor
Malin Jonsson Fagerlund
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2012
Completion date
February 29, 2016
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cpap, hypoxic ventilatory response, neuromuscular blockade, osa, rocuronium